TARGET-EU: Risk of adverse birth and neurodevelopmental outcomes in children born alive to fathers exposed to valproate versus levetiracetam for generalised epilepsy

11/05/2026
22/05/2026
EU PAS number:
EUPAS1000000999
Study
Planned
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Emulation_Protocol_CS7_REV6_clean.pdf

English (1019.19 KB - PDF) View document
Study results
Study report
Other information
Study, other information

CS7_Feasibility Assessment-2.pdf

English (311.49 KB - PDF) View document